VivoSeq
Neurology

Interscalene Brachial Plexus Block

0

Pipeline Programs

2

Active Trials

0

Companies Involved

Interscalene Brachial Plexus Block is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

17

clinical trials

Completed9 · 53%
Unknown status6 · 35%
Enrolling by invitation1 · 6%
Not yet recruiting1 · 6%

Trial Activity

17 trials

The Effects of Dexamethasone on Low Dose Interscalene Brachial Plexus Block
Completed··Phase 4·NCT02322242·182 enrolled
The Effect of Tramadol on Interscalene Brachial Plexus Block
Completed··Phase 2·NCT02182752·80 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)